Clinical trial
Feasibility Trial Evaluating Efficacy and Safety of Solitaire™ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome
NCT04692402 is registered in ClinicalTrials.gov with Paul Ong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Trial Evaluating Efficacy and Safety of Solitaire™ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome
- Lead sponsor
- Paul Ong
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 16, 2019
- Completion date
- September 30, 2022
- Enrollment
- 51 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
refractory thrombus in patients with acute coronary syndrome